Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies.

MLA

Soares, Rayla Rodrigues, et al. “Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from Preclinical Studies.” Chemico-Biological Interactions, vol. 403, Nov. 2024, p. 111229. EBSCOhost, https://doi.org/10.1016/j.cbi.2024.111229.

APA

Soares, R. R., Viggiani, L. F., Reis Filho, J. M., & Joviano-Santos, J. V. (2024). Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies. Chemico-Biological Interactions, 403, 111229. https://doi.org/10.1016/j.cbi.2024.111229

Chicago

Soares, Rayla Rodrigues, Larissa Freitas Viggiani, Juliano Moreira Reis Filho, and Julliane V Joviano-Santos. 2024. “Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from Preclinical Studies.” Chemico-Biological Interactions 403 (November): 111229. doi:10.1016/j.cbi.2024.111229.